Home >

Mergers and acquisitions integration continues, Southwest Pharmaceutical plans to acquire Orade to develop the gem industry

Data show that Southwest Pharmaceutical’s shares have risen by 135.7% since the resumption of trading on August 12 as of yesterday. The latest closing price of the stock was 17.22 yuan.

The company's reorganization plan is as follows: After the asset swap, the company plans to acquire 100% of the equity of Orred with a fixed increase of 497 million shares at 7.42 yuan/share, and plans to invest no less than 7.42 yuan/share in a fixed increase of no more than 138.814 million shares in Orred's "large-size sapphire material industry base expansion project" and Qiuguan Optoelectronics' "sapphire window film base project." The company first conducted an asset swap with Zuo Hongbo, one of the actual controllers of Orred (the estimated value of the assets to be acquired is 427 million yuan); the balance of 100% of Orred's equity after the swap was then purchased by the company through a fixed increase from the original shareholders; after the asset swap was completed, Zuo Hongbo received all the assets sold and 413 million yuan in cash to transfer Taiji Group's 29.99% stake in the company. After the completion of this transaction, the company's main business will transform into a supplier of sapphire crystal materials and single crystal furnace equipment.

It is reported that Ored is mainly engaged in the research and development, production and sales of sapphire crystal materials and single crystal furnace equipment. Its core technology is mainly reflected in the sapphire crystal growth method and its process design, the design and development of single crystal furnace equipment, etc.; it is currently one of the world's major suppliers of sapphire crystal ingots above 4 inches. Sapphire crystal materials produced before 2011 were mainly used as LED substrate materials. In 2011, they began to enter the field of consumer electronics applications, supplying sapphire materials to mobile phone component manufacturers Lens Technology and Bourne Optics. Orade's operating income from January to April 2014 was 111 million yuan, and its net profit was 21.3141 million yuan; the estimated value of all equity was 4.12 billion yuan, with a value-added rate of 590.84%.

At present, the application of sapphire on LED substrates accounts for nearly 80% of the sapphire market share. With the promotion of China's energy-saving projects, LED general lighting has entered an accelerated development stage, and the LED market has increased demand for sapphire. In addition, consumer electronics applications have provided a broad imagination for the sapphire market, and sapphire materials may be widely used in future smartphones and wearable devices.

The company's 2014 semi-annual report disclosed that during the reporting period, the company's operating income was 585 million yuan, a year-on-year decrease of 6.87%, which was due to the impact of GMP certification; the net cash flow generated from operating activities was 138 million yuan, a year-on-year increase of 78.55%, which was due to the decrease in payments for other operating activities.